Kyzatrex Featured In Research At SMSNA Fall Scientific Meeting
16 Oct 2024 //
GLOBENEWSWIRE
Marius PharmaPartners With Numan For Kyzatrex Distribution
18 Sep 2024 //
GLOBENEWSWIRE
WellSync-Marius Offer FDA-Approved Oral Testosterone Replacement Therapy
09 Sep 2024 //
PR NEWSWIRE
Vitamin Shoppe Expands Telehealth with Testosterone Therapy via KYZATREX
03 Sep 2024 //
PR NEWSWIRE
Marius Pharmaceuticals Submits KYZATREX® For Health Canada Approval
30 Jul 2024 //
GLOBENEWSWIRE
Marius Publishes Phase 3 KYZATREX® Testosterone Data
11 Apr 2024 //
PR NEWSWIRE
Marius Pharmaceuticals Expands Access of KYZATREX to Department of VA
19 Sep 2023 //
GLOBENEWSWIRE
Tolmar Announces Acquisition of JATENZO for the Treatment of Hypogonadism
27 Oct 2022 //
PRNEWSWIRE
Clarus Therapeutics Holdings,. Announces Plan for Near-Term Sale of JATENZO®
05 Sep 2022 //
GLOBENEWSWIRE
Clarus` fate in limbo as lead drug Jatenzo sputters
20 Aug 2022 //
FIERCEPHARMA
Marius Pharmaceuticals Receives FDA Approval of KYZATREX
02 Aug 2022 //
GLOBENEWSWIRE
Clarus Therapeutics to Present New Data for JATENZO at ENDO 2022
09 Jun 2022 //
GLOBENEWSWIRE
Clarus Tx Announces Notice of Allowance for Patent Claims Covering JATENZO
28 Apr 2022 //
GLOBENEWSWIRE
Clarus to Present New Data for JATENZO at Androgen Society 4th Annual Meeting
19 Apr 2022 //
GLOBENEWSWIRE
Clarus Announces Strategic Partnerships for JATENZO with Vault Health & AssistRx
24 Feb 2022 //
GLOBENEWSWIRE
Lipocine`s Partner Received FDA Acceptance Of NDA Resubmission For Tlando
03 Feb 2022 //
PRNEWSWIRE
Antares Pharma Announces FDA Acceptance of NDA Resubmission for TLANDO®
03 Feb 2022 //
GLOBENEWSWIRE
Lipocine Announces Peer-Reviewed Publication of Phase 3 Study Results for TLANDO
27 Jan 2022 //
PRNEWSWIRE
Endo Announces Publication of New AVEED Data in Peer-Reviewed Journal
13 Jan 2022 //
PRNEWSWIRE
Clarus Therapeutics Announces Two Notices of Allowance for Patent Claims
26 Oct 2021 //
GLOBENEWSWIRE
Clarus`S Expands Executive Team in Preparation for Landmark Launch of JATENZO®
11 Dec 2019 //
GLOBENEWSWIRE
Lipocine Announces Trial Date in Lipocine`s Infringement Lawsuit Against Clarus
27 Aug 2019 //
PR NEWSWIRE
Clarus Therapeutics Announces FDA Award of 3Y Market Exclusivity for Jatenzo®
19 Aug 2019 //
GLOBENEWSWIRE
Male birth control pill shows promise but needs further study
23 Mar 2018 //
FIERCE BIOTECH
Endo, Bayer Win Patent Suit for Testosterone Drug
16 Feb 2017 //
PHARMA MANUFACTURING
Paddock`s Generic Testosterone Undecanoate Receives Approval In US
09 Dec 2016 //
FDA